Douglas Young is the Fleming Professor of Medical Microbiology at Imperial College London and group leader at the Francis Crick Institute, where he leads a research team that focuses on understanding molecular mechanisms of mycobacterial pathogenesis.
After completing degrees in biochemistry from the University of Edinburgh and the University of Oxford in 1978, Prof Young was introduced to mycobacterial research during a two-year post-doctoral fellowship studying leprosy in Mumbai, India. Over the last three decades, he has worked on the microbiology and immunology of tuberculosis with appointments at the University of Washington in Seattle and with the Medical Research Council and Imperial College in London.
From 1992 to 1998, Prof Young chaired the Immunology of Mycobacteria (IMMYC) Steering Committee at the World Health Organisation, and was chair of the New Vaccines Working Group of the Stop TB Partnership from 2003 to 2006. Prof Young advises the UK Department of the Environment, Food and Rural Affairs on the use of vaccines to control bovine TB.
Prof Young was appointed a fellow of the UK Academy of Medical Sciences in 2000.
Read the more extensive biography of Douglas Young.
